Menu

Blog

Jun 8, 2023

Melanoma vaccine trial appears to reduce skin cancer recurrence

Posted by in category: biotech/medical

Drug companies Moderna and Merck have released encouraging results from a vaccine trial that shows promise in the battle against Stage 3 and Stage 4 melanoma, the most serious type of skin cancer. NBC’s Dr. Natalie Azar breaks down the findings on TODAY.

Comments are closed.